Table 5.
Geographic contribution to total population and each cluster
| Region, % patients | Total n=3,255 |
Cluster 1 (less obstruction) n=1,310 |
Cluster 2 (less obstruction, psychoanaleptic users, high comorbidity) n=238 |
Cluster 3 (greater obstruction, no pneumonia history) n=1,189 |
Cluster 4 (greater obstruction, high comorbidity, pneumonia history) n=374 |
Cluster 5 (greater obstruction, low BMI) n=144 |
|---|---|---|---|---|---|---|
| USA | 34.0 | 26.6 | 61.3 | 30.3 | 53.7 | 36.8 |
| Europe | 26.1 | 27.7 | 14.3 | 30.5 | 18.2 | 13.9 |
| Other 1 | 21.4 | 28.8 | 6.3 | 19.2 | 11.8 | 22.2 |
| Other 2 | 18.5 | 17.0 | 18.1 | 20.0 | 16.3 | 27.1 |
Notes: Other 1, Argentina, Chile, Mexico, Peru, Philippines; Other 2, Australia, Canada, South Africa. The most prevalent region in each cluster is shown in bold.
Abbreviation: BMI, body mass index.